\relax 
\providecommand\zref@newlabel[2]{}
\providecommand\hyper@newdestlabel[2]{}
\providecommand\HyperFirstAtBeginDocument{\AtBeginDocument}
\HyperFirstAtBeginDocument{\ifx\hyper@anchor\@undefined
\global\let\oldcontentsline\contentsline
\gdef\contentsline#1#2#3#4{\oldcontentsline{#1}{#2}{#3}}
\global\let\oldnewlabel\newlabel
\gdef\newlabel#1#2{\newlabelxx{#1}#2}
\gdef\newlabelxx#1#2#3#4#5#6{\oldnewlabel{#1}{{#2}{#3}}}
\AtEndDocument{\ifx\hyper@anchor\@undefined
\let\contentsline\oldcontentsline
\let\newlabel\oldnewlabel
\fi}
\fi}
\global\let\hyper@last\relax 
\gdef\HyperFirstAtBeginDocument#1{#1}
\providecommand\HyField@AuxAddToFields[1]{}
\providecommand\HyField@AuxAddToCoFields[2]{}
\bibstyle{pnas-new}
\citation{Huang2006}
\citation{Phillips2008}
\citation{Mortazavi2008}
\citation{Metzker2010}
\citation{Patro2014,Bray2016,Patro2015}
\citation{Pimentel2016,Trapnell2013}
\citation{Singer2016,Shalek2013}
\citation{Schwarz2012}
\citation{VanWolfswinkel2014,Scimone2014}
\citation{Brem2002,Schadt2003,Li2006,King2014}
\citation{Hughes2000}
\citation{VanDriessche2005}
\citation{Dixit2016}
\citation{Angeles-Albores2016a}
\citation{Epstein2001,Shen2006,Shao2009,Jiang2001}
\citation{Semenza2012}
\citation{Loenarz2011}
\citation{Jiang1996}
\citation{Jiang2001}
\citation{Powell-Coffman1998}
\citation{Semenza1994,Bishop2004,Shen2005,Bellier2009,Semenza2012}
\citation{Huang1996}
\citation{Kaelin2008}
\citation{Ma2012}
\select@language{english}
\@writefile{toc}{\select@language{english}}
\@writefile{lof}{\select@language{english}}
\@writefile{lot}{\select@language{english}}
\zref@newlabel{mdf@pagelabel-1}{\default{\caption@xref {??}{ on input line 179}}\page{1}\abspage{1}\mdf@pagevalue{1}}
\pgfsyspdfmark {pgfid1}{20424130}{7852432}
\pgfsyspdfmark {pgfid2}{19981762}{2393170}
\citation{Angeles-Albores2016a}
\citation{Shao2009}
\@writefile{lof}{\contentsline {figure}{\numberline {1}{\ignorespaces  Genetic and biochemical representation of the hypoxia pathway in \emph  {C.~elegans}{}. Red arrows are arrows that lead to inhibition of HIF-1{}, and blue arrows are arrows that increase HIF-1{} activity or are the result of HIF-1{} activity. EGL-9{} is known to exert \emph  {vhl-1}-dependent and independent repression on HIF-1{} as shown in the genetic diagram. The \emph  {vhl-1}-independent repression of HIF-1{} by EGL-9{} is denoted by a dashed line and is not dependent on the hydroxylating activity of EGL-9{}. Technically, RHY-1 inhibits CYSL-1, which in turn inhibits EGL-9, but this interaction was abbreviated in the genetic diagram for clarity. \relax }}{2}{figure.caption.1}}
\providecommand*\caption@xref[2]{\@setref\relax\@undefined{#1}}
\newlabel{fig:pathway}{{1}{2}{Genetic and biochemical representation of the hypoxia pathway in \cel {}. Red arrows are arrows that lead to inhibition of \hifp {}, and blue arrows are arrows that increase \hifp {} activity or are the result of \hifp {} activity. \eglp {} is known to exert \gene {vhl-1}-dependent and independent repression on \hifp {} as shown in the genetic diagram. The \gene {vhl-1}-independent repression of \hifp {} by \eglp {} is denoted by a dashed line and is not dependent on the hydroxylating activity of \eglp {}. Technically, RHY-1 inhibits CYSL-1, which in turn inhibits EGL-9, but this interaction was abbreviated in the genetic diagram for clarity. \relax }{figure.caption.1}{}}
\newlabel{sub:summary}{{}{2}{}{figure.caption.1}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {2}{\ignorespaces  Workflow used to quantify changes in isoform expression. After sequencing, reads are quantified using Kallisto. Differential expression is calculated using Sleuth, which outputs one $\beta $ coefficient per detected isoform per perturbation or genotype except wild-type. $\beta $ coefficients are analogous to, though not exactly the same as, the natural logarithm of the fold-change. Downstream analyses can be performed after identifying $\beta $ coefficients that are statistically significantly different from 0. This can be done because each $\beta $ coefficient is associated with a q-value. Q-values less than 0.1 are considered statistically different from 0. \relax }}{2}{figure.caption.2}}
\newlabel{fig:explain}{{2}{2}{Workflow used to quantify changes in isoform expression. After sequencing, reads are quantified using Kallisto. Differential expression is calculated using Sleuth, which outputs one $\beta $ coefficient per detected isoform per perturbation or genotype except wild-type. $\beta $ coefficients are analogous to, though not exactly the same as, the natural logarithm of the fold-change. Downstream analyses can be performed after identifying $\beta $ coefficients that are statistically significantly different from 0. This can be done because each $\beta $ coefficient is associated with a q-value. Q-values less than 0.1 are considered statistically different from 0. \relax }{figure.caption.2}{}}
\pgfsyspdfmark {pgfid3}{20276674}{2393170}
\citation{Yeung2001}
\citation{Angeles-Albores2016a}
\citation{Epstein2001,Shen2006}
\@writefile{lot}{\contentsline {table}{\numberline {1}{\ignorespaces Number of differentially expressed genes in each mutant with respect to wildtype (N2).\relax }}{3}{table.caption.3}}
\newlabel{tab:genes}{{1}{3}{Number of differentially expressed genes in each mutant with respect to wildtype (N2).\relax }{table.caption.3}{}}
\newlabel{sub:Clustering}{{}{3}{}{table.caption.3}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {3}{\ignorespaces  Principal component analysis of various \emph  {C.~elegans}{} mutants. Genotypes that have an activated hypoxia response (\emph  {i.e}, \emph  {\unhbox \voidb@x \hbox {egl-9}(lf)}{}, \emph  {\unhbox \voidb@x \hbox {vhl-1}(lf)}{}, and \emph  {\unhbox \voidb@x \hbox {rhy-1}(lf)}{}) cluster far from \emph  {\unhbox \voidb@x \hbox {hif-1(lf)}}{}. \emph  {\unhbox \voidb@x \hbox {hif-1(lf)}}{} clusters with the suppressed \emph  {\unhbox \voidb@x \hbox {egl-9(lf)}~\unhbox \voidb@x \hbox {hif-1(lf)}}{} double mutant. The \emph  {\unhbox \voidb@x \hbox {fog-2(lf)}}{} transcriptome, used as an outgroup, is far away from either cluster. \relax }}{3}{figure.caption.4}}
\newlabel{fig:pca}{{3}{3}{Principal component analysis of various \cel {} mutants. Genotypes that have an activated hypoxia response (\emph {i.e}, \egl {}, \vhl {}, and \rhy {}) cluster far from \hif {}. \hif {} clusters with the suppressed \eglhif {} double mutant. The \fog {} transcriptome, used as an outgroup, is far away from either cluster. \relax }{figure.caption.4}{}}
\newlabel{sec:reconstruct}{{}{3}{}{figure.caption.4}{}}
\newlabel{sec:phenotypes}{{}{3}{}{figure.caption.4}{}}
\pgfsyspdfmark {pgfid4}{19981762}{2393170}
\citation{Huang2006}
\citation{Shao2009}
\pgfsyspdfmark {pgfid5}{20276674}{2393170}
\@writefile{lof}{\contentsline {figure}{\numberline {4}{\ignorespaces  (\textbf  {A}) Schematic diagram of an epistasis plot. The X-axis on an epistasis plot is the expected coefficient for a double mutant under an additive model (null model). The Y-axis plots deviations from this model. Double mutants that deviate in a systematic manner from the null model exhibit transcriptome-wide epistasis ($s$). To measure $s$, we perform a linear regression on the data. The slope of the line of best fit is $s$. This coefficient is related to genetic architectures. Genes that act additively on a phenotype \textbf  {(Ph)} will have $s=0$ (orange line); whereas genes that act along an unbranched pathway will have $s=-1/2$ (blue line). Strong repression is reflected by $s=-1$ (red line). Cases where $s>0$ correspond to synthetic interactions (purple line), and in the limit as $s\rightarrow \infty $, the synthetic interaction must be an OR-gate. Cases where $0 < s < -1/2$ correspond to circuits that have multiple positive branches; whereas cases where $-1/2<s< -1$ correspond to cases where the branches have different valence. Cases where $s < -1$ represent inhibitory branches. (\textbf  {B}) Epistasis plot showing that the \emph  {\unhbox \voidb@x \hbox {egl-9(lf);vhl-1(lf)}}{} transcriptome deviates significantly from a null additive. Points are colored qualitatively according to density (purple---low, yellow---high) and size is inversely proportional to the standard error (S.E.) of the y-axis (larger points, higher accuracy). The purple line is the line of best fit from an orthogonal distance regression. (\textbf  {C}) Comparison of simulated epistatic coefficients against the observed coefficient. Green curve shows the bootstrapped observed transcriptome-wide epistasis coefficient for \emph  {egl-9} and \emph  {vhl-1}. Dashed green line shows the mean value of the data. Using the single mutants, we simulated coefficient distributions for a linear model (light blue, centered at $-0.5$); an additive model (orange, centered at 0); a model where either \emph  {egl-9} or \emph  {vhl-1} masks the other phenotype (dark blue and black, respectively) and a complete suppression epistasis model (red, centered at $-1$). The observed coefficient overlaps the predicted epistasis curve for \emph  {\unhbox \voidb@x \hbox {egl-9(lf);vhl-1(lf)}}{} = \emph  {\unhbox \voidb@x \hbox {egl-9}(lf)}{} (green and dark blue). \relax }}{5}{figure.caption.5}}
\newlabel{fig:egl9epistasis}{{4}{5}{(\textbf {A}) Schematic diagram of an epistasis plot. The X-axis on an epistasis plot is the expected coefficient for a double mutant under an additive model (null model). The Y-axis plots deviations from this model. Double mutants that deviate in a systematic manner from the null model exhibit transcriptome-wide epistasis ($s$). To measure $s$, we perform a linear regression on the data. The slope of the line of best fit is $s$. This coefficient is related to genetic architectures. Genes that act additively on a phenotype \textbf {(Ph)} will have $s=0$ (orange line); whereas genes that act along an unbranched pathway will have $s=-1/2$ (blue line). Strong repression is reflected by $s=-1$ (red line). Cases where $s>0$ correspond to synthetic interactions (purple line), and in the limit as $s\rightarrow \infty $, the synthetic interaction must be an OR-gate. Cases where $0 < s < -1/2$ correspond to circuits that have multiple positive branches; whereas cases where $-1/2<s< -1$ correspond to cases where the branches have different valence. Cases where $s < -1$ represent inhibitory branches. (\textbf {B}) Epistasis plot showing that the \eglvhl {} transcriptome deviates significantly from a null additive. Points are colored qualitatively according to density (purple---low, yellow---high) and size is inversely proportional to the standard error (S.E.) of the y-axis (larger points, higher accuracy). The purple line is the line of best fit from an orthogonal distance regression. (\textbf {C}) Comparison of simulated epistatic coefficients against the observed coefficient. Green curve shows the bootstrapped observed transcriptome-wide epistasis coefficient for \gene {egl-9} and \gene {vhl-1}. Dashed green line shows the mean value of the data. Using the single mutants, we simulated coefficient distributions for a linear model (light blue, centered at $-0.5$); an additive model (orange, centered at 0); a model where either \gene {egl-9} or \gene {vhl-1} masks the other phenotype (dark blue and black, respectively) and a complete suppression epistasis model (red, centered at $-1$). The observed coefficient overlaps the predicted epistasis curve for \eglvhl {} = \egl {} (green and dark blue). \relax }{figure.caption.5}{}}
\newlabel{sub:decorrelation}{{}{5}{}{figure.caption.5}{}}
\newlabel{sub:topology}{{}{5}{}{figure.caption.6}{}}
\pgfsyspdfmark {pgfid6}{19981762}{2393170}
\citation{Ma2012}
\citation{Park2012}
\@writefile{lof}{\contentsline {figure}{\numberline {5}{\ignorespaces  Theoretically, transcriptomes can be used to order genes in a pathway under certain assumptions. Arrows in the diagrams above are intended to show the direction of flow, and do not indicate valence. \textbf  {A}. A linear pathway in which \emph  {rhy-1} is the only gene controlling \emph  {egl-9}, which in turn controls \emph  {hif-1} does not contain information to infer the order between genes. \textbf  {B}. If \emph  {rhy-1} and \emph  {egl-9} have transcriptomic effects that are separable from \emph  {hif-1}, then the \emph  {rhy-1} transcriptome should contain contributions from \emph  {egl-9}, \emph  {hif-1} and \emph  {egl-9}- and \emph  {hif-1}-independent pathways. This pathway contains enough information to infer order. \textbf  {C}. If a pathway is branched both upstream and downstream, transcriptomes will show even faster decorrelation. Nodes that are separated by many edges may begin to behave almost independently of each other with marginal transcriptomic overlap or correlation. \textbf  {D}. The hypoxia pathway can be ordered. We hypothesize the rapid decay in correlation is due to a mixture of upstream and downstream branching that happens along this pathway. Bars show the standard error of the weighted coefficient from the Monte Carlo Markov Chain computations. \relax }}{6}{figure.caption.6}}
\newlabel{fig:decorrelation}{{5}{6}{Theoretically, transcriptomes can be used to order genes in a pathway under certain assumptions. Arrows in the diagrams above are intended to show the direction of flow, and do not indicate valence. \textbf {A}. A linear pathway in which \gene {rhy-1} is the only gene controlling \gene {egl-9}, which in turn controls \gene {hif-1} does not contain information to infer the order between genes. \textbf {B}. If \gene {rhy-1} and \gene {egl-9} have transcriptomic effects that are separable from \gene {hif-1}, then the \gene {rhy-1} transcriptome should contain contributions from \gene {egl-9}, \gene {hif-1} and \gene {egl-9}- and \gene {hif-1}-independent pathways. This pathway contains enough information to infer order. \textbf {C}. If a pathway is branched both upstream and downstream, transcriptomes will show even faster decorrelation. Nodes that are separated by many edges may begin to behave almost independently of each other with marginal transcriptomic overlap or correlation. \textbf {D}. The hypoxia pathway can be ordered. We hypothesize the rapid decay in correlation is due to a mixture of upstream and downstream branching that happens along this pathway. Bars show the standard error of the weighted coefficient from the Monte Carlo Markov Chain computations. \relax }{figure.caption.6}{}}
\pgfsyspdfmark {pgfid7}{20276674}{2393170}
\citation{Ackerman2012,Romney2011}
\citation{Ackerman2012}
\newlabel{sub:hifoh}{{}{7}{}{figure.caption.6}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {6}{\ignorespaces  \textbf  {A}. 56{} genes in \emph  {C.~elegans}{} exhibit non-classical epistasis in the hypoxiapathway, characterized by opposite effects on gene expression, relative to the wild-type, of of the \emph  {\unhbox \voidb@x \hbox {vhl-1}(lf)}{} compared to \emph  {\unhbox \voidb@x \hbox {egl-9}(lf)}{} (or \emph  {\unhbox \voidb@x \hbox {rhy-1}(lf)}{}) mutants. Shown are a random selection of 15 the 56{} genes for illustrative purposes. \textbf  {B}. Genes that behave non-canonically have a consistent pattern. \emph  {\unhbox \voidb@x \hbox {vhl-1}(lf)}{} mutants have an opposite effect to \emph  {\unhbox \voidb@x \hbox {egl-9}(lf)}{}, but \emph  {egl-9} remains epistatic to \emph  {vhl-1} and loss-of-function mutations in \emph  {hif-1} suppress the \emph  {\unhbox \voidb@x \hbox {egl-9}(lf)}{} phenotype. Asterisks show $\beta $ values significantly different from 0 relative to wild-type ($q<10^{-1}$). \relax }}{7}{figure.caption.7}}
\newlabel{fig:hif1oh}{{6}{7}{\textbf {A}. \hifohtargets {} genes in \cel {} exhibit non-classical epistasis in the hypoxiapathway, characterized by opposite effects on gene expression, relative to the wild-type, of of the \vhl {} compared to \egl {} (or \rhy {}) mutants. Shown are a random selection of 15 the \hifohtargets {} genes for illustrative purposes. \textbf {B}. Genes that behave non-canonically have a consistent pattern. \vhl {} mutants have an opposite effect to \egl {}, but \gene {egl-9} remains epistatic to \gene {vhl-1} and loss-of-function mutations in \gene {hif-1} suppress the \egl {} phenotype. Asterisks show $\beta $ values significantly different from 0 relative to wild-type (\qval {1}). \relax }{figure.caption.7}{}}
\pgfsyspdfmark {pgfid8}{19981762}{2393170}
\citation{Ackerman2012,Romney2011,Luhachack2012}
\citation{Romney2011,Ackerman2012}
\citation{Luhachack2012}
\citation{Shao2010}
\citation{Wang1993}
\citation{Goentoro2009a}
\citation{Hart2012,Hart2013}
\newlabel{sec:discussion}{{}{8}{}{figure.caption.7}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {7}{\ignorespaces  A hypothetical model showing a mechanism where HIF-1{}-hydroxyl antagonises HIF-1{}. \textbf  {A}. Diagram showing that RHY-1 activates EGL-9. EGL-9 hydroxylates HIF-1 in an oxygen dependent fashion. Under normoxia, HIF-1 is rapidly hydroxylated and only slowly does hydroxylated HIF-1 return to its original state. EGL-9 can also inhibit HIF-1 in an oxygen-independent fashion. HIF-1 hydroxyl is rapidly degraded in a VHL-1 dependent fashion. In our model, HIF-1 and HIF-1 hydroxyl have opposing effects on transcription. The width of the arrows represents the rates under normoxic conditions. \textbf  {B}. Table showing the effects of loss-of-function mutations on HIF-1 and HIF-1 hydroxyl activity, showing how this can potentially explain the behavior of \emph  {ftn-1} in each case. S.S = Steady-state. \relax }}{8}{figure.caption.8}}
\newlabel{fig:hif1oh_table}{{7}{8}{A hypothetical model showing a mechanism where \hifp {}-hydroxyl antagonises \hifp {}. \textbf {A}. Diagram showing that RHY-1 activates EGL-9. EGL-9 hydroxylates HIF-1 in an oxygen dependent fashion. Under normoxia, HIF-1 is rapidly hydroxylated and only slowly does hydroxylated HIF-1 return to its original state. EGL-9 can also inhibit HIF-1 in an oxygen-independent fashion. HIF-1 hydroxyl is rapidly degraded in a VHL-1 dependent fashion. In our model, HIF-1 and HIF-1 hydroxyl have opposing effects on transcription. The width of the arrows represents the rates under normoxic conditions. \textbf {B}. Table showing the effects of loss-of-function mutations on HIF-1 and HIF-1 hydroxyl activity, showing how this can potentially explain the behavior of \gene {ftn-1} in each case. S.S = Steady-state. \relax }{figure.caption.8}{}}
\pgfsyspdfmark {pgfid9}{20276674}{2393170}
\citation{Dixit2016,Angeles-Albores2016a}
\citation{Storey2003}
\@writefile{toc}{\contentsline {matmethods@section}{\numberline {1}Materials and Methods}{9}{matmethods@section.1}}
\pgfsyspdfmark {pgfid10}{19981762}{2393170}
\citation{Picelli2014}
\citation{Picelli2014}
\citation{Team2014,McKinney2011,Oliphant2007,Pedregosa2012,Salvatier2015,VanDerWalt2011,Hunter2007,Angeles-Albores2016,Waskom}
\citation{Perez2007}
\citation{Salvatier2015}
\citation{Angeles-Albores2016b,Angeles-Albores2016}
\bibdata{citations}
\bibcite{Huang2006}{{1}{}{{}}{{}}}
\newlabel{eq:epi}{{3}{10}{}{equation.0.3}{}}
\newlabel{eq:free_model}{{4}{10}{}{equation.0.4}{}}
\pgfsyspdfmark {pgfid11}{20276674}{2393170}
\bibcite{Phillips2008}{{2}{}{{}}{{}}}
\bibcite{Mortazavi2008}{{3}{}{{}}{{}}}
\bibcite{Metzker2010}{{4}{}{{}}{{}}}
\bibcite{Patro2014}{{5}{}{{}}{{}}}
\bibcite{Bray2016}{{6}{}{{}}{{}}}
\bibcite{Patro2015}{{7}{}{{}}{{}}}
\bibcite{Pimentel2016}{{8}{}{{}}{{}}}
\bibcite{Trapnell2013}{{9}{}{{}}{{}}}
\bibcite{Singer2016}{{10}{}{{}}{{}}}
\bibcite{Shalek2013}{{11}{}{{}}{{}}}
\bibcite{Schwarz2012}{{12}{}{{}}{{}}}
\bibcite{VanWolfswinkel2014}{{13}{}{{}}{{}}}
\bibcite{Scimone2014}{{14}{}{{}}{{}}}
\bibcite{Brem2002}{{15}{}{{}}{{}}}
\bibcite{Schadt2003}{{16}{}{{}}{{}}}
\bibcite{Li2006}{{17}{}{{}}{{}}}
\bibcite{King2014}{{18}{}{{}}{{}}}
\bibcite{Hughes2000}{{19}{}{{}}{{}}}
\bibcite{VanDriessche2005}{{20}{}{{}}{{}}}
\bibcite{Dixit2016}{{21}{}{{}}{{}}}
\bibcite{Angeles-Albores2016a}{{22}{}{{}}{{}}}
\bibcite{Epstein2001}{{23}{}{{}}{{}}}
\bibcite{Shen2006}{{24}{}{{}}{{}}}
\bibcite{Shao2009}{{25}{}{{}}{{}}}
\bibcite{Jiang2001}{{26}{}{{}}{{}}}
\bibcite{Semenza2012}{{27}{}{{}}{{}}}
\bibcite{Loenarz2011}{{28}{}{{}}{{}}}
\bibcite{Jiang1996}{{29}{}{{}}{{}}}
\bibcite{Powell-Coffman1998}{{30}{}{{}}{{}}}
\bibcite{Semenza1994}{{31}{}{{}}{{}}}
\bibcite{Bishop2004}{{32}{}{{}}{{}}}
\bibcite{Shen2005}{{33}{}{{}}{{}}}
\bibcite{Bellier2009}{{34}{}{{}}{{}}}
\bibcite{Huang1996}{{35}{}{{}}{{}}}
\bibcite{Kaelin2008}{{36}{}{{}}{{}}}
\bibcite{Ma2012}{{37}{}{{}}{{}}}
\bibcite{Yeung2001}{{38}{}{{}}{{}}}
\bibcite{Park2012}{{39}{}{{}}{{}}}
\bibcite{Ackerman2012}{{40}{}{{}}{{}}}
\bibcite{Romney2011}{{41}{}{{}}{{}}}
\bibcite{Luhachack2012}{{42}{}{{}}{{}}}
\bibcite{Shao2010}{{43}{}{{}}{{}}}
\bibcite{Wang1993}{{44}{}{{}}{{}}}
\bibcite{Goentoro2009a}{{45}{}{{}}{{}}}
\bibcite{Hart2012}{{46}{}{{}}{{}}}
\bibcite{Hart2013}{{47}{}{{}}{{}}}
\bibcite{Storey2003}{{48}{}{{}}{{}}}
\bibcite{Picelli2014}{{49}{}{{}}{{}}}
\bibcite{Team2014}{{50}{}{{}}{{}}}
\bibcite{McKinney2011}{{51}{}{{}}{{}}}
\bibcite{Oliphant2007}{{52}{}{{}}{{}}}
\bibcite{Pedregosa2012}{{53}{}{{}}{{}}}
\bibcite{Salvatier2015}{{54}{}{{}}{{}}}
\bibcite{VanDerWalt2011}{{55}{}{{}}{{}}}
\bibcite{Hunter2007}{{56}{}{{}}{{}}}
\bibcite{Angeles-Albores2016}{{57}{}{{}}{{}}}
\bibcite{Waskom}{{58}{}{{}}{{}}}
\bibcite{Perez2007}{{59}{}{{}}{{}}}
\bibcite{Angeles-Albores2016b}{{60}{}{{}}{{}}}
\xwm@secstopagerange{{10000}{11}}
\providecommand\NAT@force@numbers{}\NAT@force@numbers
\pgfsyspdfmark {pgfid12}{19981762}{2393170}
\newlabel{LastPage}{{}{11}{}{page.11}{}}
\xdef\lastpage@lastpage{11}
\xdef\lastpage@lastpageHy{11}
\newlabel{xwmlastpage}{{1}{11}{Materials and Methods\relax }{equation.0.5}{}}
